Significance of thymidine phosphorylase in HCC with chronic liver disease for long-term postoperative recurrence

Journal of Surgical Oncology

Volumn 83, Issue 3, 2003, Pages 173-179

  Ezaki, Takahiro ^a,b   Ikegami, Toru ^a   Ishida, Teruyoshi ^a   Aimitsu, Shiomi ^a   Mori, Masaki ^a   Fujihara, Megumu ^a  

^a ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^b National Fukuoka Higashi Hospital   (Japan)

Author keywords

Hepatocellular carcinoma; Prognosis; Recurrence; Thymidine phosphorylase

Indexed keywords

THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC LIVER DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HEPATITIS, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PROGNOSIS; THYMIDINE PHOSPHORYLASE;

EID: 0038354960     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10259     Document Type: Article

References (27)

1. Belghiti J, Panis Y, Farges O, et al.: Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-117.
2. Ezaki T, Koyanagi N, Yamagata M, et al.: Postoperative recurrence of solitary small hepatocellular carcinoma. J Surg Oncol 1996;62:115-122.
3. Nishida M, Hino A, Mori K, et al.: Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 1996;19:1407-1411.
4. Haraguchi M, Miyadera K, Uemura K, et al.: Angiogenic activity of enzymes. Nature 1994;368:198.
5. Yoshimura A, Kuwazuru Y, Furukawa T, et al.: Purification and tissue distribution of human thymidine phosphorylase: High expression in lymphocytes, reticulocytes, and tumors. Biochim Biophys Acta 1990;1034:107-113.
6. Yamachika T, Nakanishi H, Inada K, et al.: A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer 1998;82:70-77.
7. Kuniyasu T, Nakamura T, Tabuchi Y, et al.: Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: The clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness. Cancer 1998;83:1300-1306.
8. Yoshikawa T, Suzuki K, Kobayashi O, et al.: Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer. Br J Cancer 1999;79:1145-1150.
9. Child CG, Turcotte JG, (editors): Surgery and portal hypertension In: The liver and portal hypertension. Philadelphia: WB Saunders, 1964. pp 49-51.
10. Eda H, Fujimoto K, Watanabe S, et al.: Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 1993;32:333-338.
11. Sakon M, Umeshita K, Nagano H, et al.: Clinical significance of hepatic resection in hepatocellular carcinoma. Analysis by disease-free survival curves Arch Surg 2000;135:1456-1459.
12. Takenaka K, Adachi E, Nishizaki T, et al.: Possible multicentric occurrence of hepatocellular carcinoma: A clinicopathological study. Hepatology 1993;19:889-894.
13. Miyagawa S, Kawasaki S, Makuuchi M: Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: Tumor multicentricity in cirrhotic liver wth hepatitis C. Hepatology 1996;24:307-310.
14. Hsu HC, Chiou TJ, Chen JY, et al.: Clonality and clonal evolution of hepatocellular carcinoma with multiple nodules. Hepatology 1991;13:923-928.
15. Sheu JC, Huang GT, Chou HC, et al.: Multiple hepatocellular carcinoma at early stage have different clonality. Gastroenterology 1993;105:1471-1476.
16. Edamitsu O: Pathomorphologic study on tumor vessels of hepatocellular carcinoma. Acta Hepatol Jpn 1992;33:15-20.
17. Nakashima O, Sugihara S, Kage M: Pathomorphologic characteristics of small hepatocellular carcinoma: A special reference to characteristics of small hepatocellular carcinoma with indistinct margins. Hepatology 1995;22:101-105.
18. Sakamoto M, Ino Y, Fujii T, et al.: Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma. Jpn J Clin Oncol 1993;23:98-104.
19. Takayasu K, Shima Y, Muramatsu Y, et al.: Angiography of small hepatocellular carcinomas; analysis of 105 resected tumors. AJR Am J Roentgenol 1986;147:525-529.
20. Di Bisceglie AM: Natural history of hepatitis C: Its impact on clinical management. Hepatology 2000;31:1014-1018.
21. Borzio M, Bruno S, Roncalli M: Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study. Gastroenterology 1998;108:812-816.
22. Shibata M, Morizane T, Uchida T, et al.: Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet 1998;351:1773-1777.
23. Donato MF, Arosio E, Ninno ED, et al.: High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology 2001;34:523-528.
24. Mazzanti R, Messerini L, Monsacchi L, et al.: Chronic viral hepatitis indeced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis. Hepatology 1997;25:229-234.
25. Kubo S, Hirohashi K, Tanaka H, et al.: Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. World J Surg 2000;24:1559-1565.
26. Ikeda K, Saitoh S, Koida I, et al.: A multivariate analysis of risk factors for hepatocellular carcinogenesis A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
27. Yoshida H, Shiratori Y, Moriyama M, et al.: Interferon therapy reduces the risk for hepatocellular carcinoma: National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 1999;131:174-181.